» Articles » PMID: 26291456

High Transmitter CD4+ T-Cell Count Shortly After the Time of Transmission in a Study of African Serodiscordant Couples

Overview
Journal PLoS One
Date 2015 Aug 21
PMID 26291456
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: 2013 WHO guidelines recommend starting ART at CD4+ T-cell counts ≤500 cells/μL. We present the T-cell counts from adult Africans with HIV shortly following transmission to their sexual partners.

Methods: HIV-discordant couples in Zambia, Uganda and Rwanda were followed prospectively and received couples counseling and condoms. HIV uninfected partners were tested for HIV at least quarterly and HIV-infected partners received HIV care and referral for ART per national guidelines. Upon diagnosis of incident HIV infection in the previously HIV-uninfected partner, a blood sample was collected from both partners to measure CD4+ T-cells and perform viral linkage. The estimated date of infection (EDI) of the incident case was calculated based on testing history. EDI was unknown for suspected transmitting partners.

Results: From 2006-2011, 4,705 HIV-discordant couples were enrolled in this cohort, and 443 cases of incident HIV infection were documented. Virus linkage analysis was performed in 374 transmission pairs, and 273 (73%) transmissions were linked genetically. CD4 counts in the transmitting partner were measured a median of 56 days after EDI (mean:90.5, min:10, max:396). The median CD4 count was 339 cells/μl (mean:386.4, min:15, max:1,434), and the proportion of partners with a CD4+ T-cell count above 500/μl was 25% (95% CI:21, 31).

Conclusions: In our cohort of discordant couples, 73% of HIV transmissions occurred within the relationship, and the transmitter CD4+ T cell count shortly after the transmission event was frequently higher than the WHO 2013 ART-initiation guidelines.

Citing Articles

High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.

Agolory S, Auld A, Odafe S, Shiraishi R, Dokubo E, Swaminathan M PLoS One. 2017; 12(9):e0183823.

PMID: 28863160 PMC: 5581182. DOI: 10.1371/journal.pone.0183823.

References
1.
Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N . Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365(6):493-505. PMC: 3200068. DOI: 10.1056/NEJMoa1105243. View

2.
Eshleman S, Hudelson S, Redd A, Wang L, Debes R, Chen Y . Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J Infect Dis. 2011; 204(12):1918-26. PMC: 3209811. DOI: 10.1093/infdis/jir651. View

3.
El-Sadr W, Coburn B, Blower S . Modeling the impact on the HIV epidemic of treating discordant couples with antiretrovirals to prevent transmission. AIDS. 2011; 25(18):2295-9. PMC: 4699795. DOI: 10.1097/QAD.0b013e32834c4c22. View

4.
Wubshet M, Berhane Y, Worku A, Kebede Y . Death and seeking alternative therapy largely accounted for lost to follow-up of patients on ART in northwest Ethiopia: a community tracking survey. PLoS One. 2013; 8(3):e59197. PMC: 3601069. DOI: 10.1371/journal.pone.0059197. View

5.
Fast P, Price M, Rida W, Kamali A, Karita E . WHO's new guidelines for antiretroviral treatment. Lancet. 2013; 382(9907):1778-9. DOI: 10.1016/S0140-6736(13)62539-8. View